CI vs RNXT · P/E 2.4, rev $274.90B vs rev $266.0K
Cigna Corp (CI) versus RenovoRx Inc (RNXT) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported RNXT revenue for 2025-09-30 was $266.0K. Net income was -$2.9M. Revenue was down 37.0% from 2025-06-30 to 2025-09-30. RNXT currently screens at market cap $47.0M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. RNXT currently screens at market cap $47.0M.
Not investment advice. Open the CI and RNXT stock pages for the full models.
Not investment advice.